KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Pharmacy, School of
    • Pharmacy Scholarly Works
    • View Item
    •   KU ScholarWorks
    • Pharmacy, School of
    • Pharmacy Scholarly Works
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Paclitaxel Succinate Analogs: Anionic Introduction as a Strategy to Impart Blood Brain Barrier Permeability

    Thumbnail
    View/Open
    AUDUS_AFD_Turunen et al BMCL 2008.pdf (120.1Kb)
    Issue Date
    2008
    Author
    Turunen, Brandon J.
    Ge, Haibo
    Oyetunji, Jariat
    Desino, Kelly Elizabeth
    Vasandani, Veena
    Himes, Richard H.
    Audus, Kenneth L.
    Seelig, Anna
    Georg, Gunda I.
    Publisher
    Elsevier
    Type
    Article
    Article Version
    Scholarly/refereed, author accepted manuscript
    Metadata
    Show full item record
    Abstract
    A focused library of TX-67 (C10 hemi-succinate) analogs have been prepared including regioisomeric, functional group, and one-carbon homologs. These were prepared to investigate TX-67’s lack of interaction with P-glycoprotein (Pgp). Tubulin stabilization ability, cytotoxicity, and Pgp interactions were evaluated. All carboxylic acid analogs had no apparent interactions with Pgp whereas the ester variants of the same compounds displayed characteristics of Pgp substrates. Furthermore, it is demonstrated that hydrogen-bonding properties were significant with respect to Pgp interactions. This anionic introduction strategy may allow for delivery of paclitaxel into the CNS as well as establishing a new method for delivery of other, non-CNS permeable drugs.
    URI
    http://hdl.handle.net/1808/7494
    DOI
    https://doi.org/10.1016/j.bmcl.2008.09.103
    Collections
    • Pharmacy Scholarly Works [286]
    Citation
    Turunen, Brandon et al. (2008). Paclitaxel Succinate Analogs: Anionic Introduction as a Strategy to Impart Blood Brain Barrier Permeability. Bioorganic & Medicinal Chemistry Letters 18(22):5971–5974. www.dx.doi.org/10.1016/j.bmcl.2008.09.103

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps